Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Study ID: NCT05753722
Start Date: 2023-03-03
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

270

Intervention / Treatment

PRTH-101

Pembrolizumab

Sponsor

Incendia Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue

Study ID: NCT01294072
Start Date: 2011-01
End Date: 2024-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

35

Intervention / Treatment

curcumin

Curcumin conjugated with plant exosomes

No intervention

Sponsor

University of Louisville

Source: clinicaltrials.gov

Share:
Add to list

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Study ID: NCT05705531
Start Date: 2023-08-18
End Date: 2028-10-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

230

Intervention / Treatment

Biospecimen Collection

Electronic Health Record Review

Magnetic Resonance Imaging

Survey Administration

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

18F-Fluciclovine PET-MRI in High-grade Glioma

Study ID: NCT05553041
Start Date: 2024-08-07
End Date: 2027-12
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

30

Intervention / Treatment

18F-Fluciclovine PET-MRI

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Study ID: NCT05355701
Start Date: 2022-07-05
End Date: 2028-09-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

156

Intervention / Treatment

PF-07799933

binimetinib

cetuximab

midazolam

fluorouracil

leucovorin

oxaliplatin

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

Study ID: NCT06954337
Start Date: 2025-05-01
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1750

Intervention / Treatment

Usual practice pattern (UPP)

Experimental: Enhanced Telehealth (ET)

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Study ID: NCT03863145
Start Date: 2022-06-14
End Date: 2026-06-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

90

Intervention / Treatment

CB-03-10

Sponsor

Cosmo Technologies Ltd

Source: clinicaltrials.gov

Share:
Add to list

ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Study ID: NCT06922539
Start Date: 2025-11-28
End Date: 2028-10-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

44

Intervention / Treatment

Fenretinide

Fenretinide

Sponsor

SciTech Development, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Study ID: NCT05491512
Start Date: 2022-08-04
End Date: 2026-08-04
Study Type

Interventional

Study Phase

Phase2

No. of Participants

121

Intervention / Treatment

18 F-FMISO PET/CT

Radiation

Cisplatin

Carboplatin

5-fluorouracil

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Resilience and Equity in Aging, Cancer, and Health (REACH)

Study ID: NCT04674267
Start Date: 2022-01-18
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

257

Intervention / Treatment

Phase 2 Intervention - Geriatric Co-Management

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list